Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion modelH Kawai, H Nakai, M Suga, et al.
The EMBO Journal|May 1, 1985
Close structural resemblance between putative polymerase of a Drosophila transposable genetic element 17.6 and pol gene product of Moloney murine leukaemia virusH Toh, R Kikuno, H Hayashida, et al.
Journal of Chemotherapy (Florence, Italy)|April 15, 2005
Treatment of a Gilbert's syndrome patient with irinotecan, leucovorin and 5-fluorouracilY Komatsu, M Takei, S Yuki, et al.
ESMO Open|August 29, 2025
A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)M Wakabayashi, H Taniguchi, A Makiyama, et al.
ESMO Open|June 13, 2021
Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancerK Kato, T Masuishi, K Fushiki, et al.
British Journal of Cancer|November 28, 2013
Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancerK Shitara, S Yuki, D Tahahari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trialY Yamada, T Denda, M Gamoh, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in BRAF V600E-mutated metastatic colorectal cancer: GI-SCREEN post-hoc analysisM Imai, Y Nakamura, T Denda, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancerH Bando, Y Tsukada, S Kumagai, et al.
ESMO Open|October 31, 2025
FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancerT Hashimoto, N Iida, S Kadowaki, et al.
Pageof 3